2026-10-28T01:55:06Zhttps://kostu-rdlopen.rawdatalibrary.net/oai/request

oai:kostu-rdlopen.rawdatalibrary.net:kostu/109742026-10-27T23:53:53Zopenairecom_kostu_10000col_kostu_10001

Suppressing Liver Cancer via the VEGFR1 Receptor using De novo Ellagic Acid Derivatives and Co-drugs: Comprehensive In silico Biochemistry Research with ADMET, RMSD, Molecular Docking, and Molecular Dynamics SimulationsAgar, SAcar, EAldemir, OGokoluk, EIssa, GBogdanov, J2026Articlehttps://rdlopen.rawdatalibrary.net/r/kostu/10974https://doi.org/10.2174/0115680266507814260929070719Curr Top Med Cheminfo:eu-repo/semantics/closedAccessinfo:eu-repo/semantics/articlehttps://kostu-rdlopen.rawdatalibrary.net/tr/items/kostu/10974